INS and Hyperglycemia: Two of the MODY3 patients were instructed to take their usual long-acting insulin dose the night before metabolic testing to prevent marked hyperglycemia and we acknowledge that this might have affected some of the fasting profiles; however, this should not have influenced the estimation of insulin secretion as none of the MODY3 patients injected short acting insulin the morning of the meal test.